Search

everythinglearnresearchcommunity

for

Search:↓

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Finasteride reduces prostate size and serum levels, helping manage benign prostatic hyperplasia, without affecting prostate cancer detection. Regular monitoring is needed for users.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Aging men face unique health issues like erectile dysfunction, prostate problems, and baldness.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

CT scans can find serious prostate cancer even when PSA levels are low.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Serum triglyceride levels are not linked to prostate cancer risk.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Hair loss gene linked to prostate issues.

Oral finasteride works better than topical minoxidil for hair growth, both are safe.

Finasteride can treat prostatic haematuria, but its use is controversial.